Chinese Firms Adopt Different Tacks For Global Expansion
This article was originally published in PharmAsia News
Executive Summary
Being home to more than 200 million people over 60 years old, China no doubt has its attractions to foreign pharma firms, especially those specialized in chronic diseases. But recently, a select group of highly competitive Chinese companies has made clear their ambitions to move the other way and test the global market.